Transdermal Administration [ftcn]
Estradiol [horm, phsu, strd]
Norethisterone [horm, phsu, strd]
Effect [qlco]
Uterus [bpoc]
Uterine Arteries [bpoc]
Objective [inpr]
To [qlco]
Evaluate [ftcn]
short [qlco]
Long-Term Effect [phpr]
Uterus [bpoc]
Endometrium [bpoc]
vascular reactivity [clna]
Uterine Arteries [bpoc]
Sequential [idcn]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
MU/day [qnco]
g% [qnco]
Norethisterone [horm, phsu, strd]
mg day [qnco]
Last [qlco]
days [tmco]
Cycle [tmco]
Design [acty]
Intravaginal [spco]
Ultrasound [diap]
Evaluation [ftcn]
Performed [ftcn]
postmenopausal [tmco]
Women [popg]
month [tmco]
treatment [ftcn]
Last [qlco]
days [tmco]
Estradiol [horm, phsu, strd]
Alone [qnco]
Estradiol + Norethisterone [horm, phsu, strd]
Plus [qlco]
endometrial biopsy [diap]
Performed [ftcn]
End [spco]
treatment [ftcn]
participants [popg]
Intravaginal [spco]
Ultrasound [diap]
endometrial biopsy [diap]
Repeated [ftcn]
months [tmco]
treatment [ftcn]
Result [ftcn]
Uterine [bpoc]
P NOS [aapp, imft]
endometrium thickness [qnco]
P NOS [aapp, imft]
Increased [qnco]
Further [spco]
increases [ftcn]
Thickness [qlco]
Similar [qlco]
Estradiol [horm, phsu, strd]
Estradiol + Norethisterone [horm, phsu, strd]
Phase [tmco]
Endometrial Hyperplasia [dsyn]
Found [qnco]
One [qnco]
Participant [popg]
months [tmco]
treatment [ftcn]
Decrease [qlco]
P NOS [aapp, imft]
Pulsatility index [clna]
Uterine Arteries [bpoc]
Observed [ftcn]
Only [qnco]
Estradiol [horm, phsu, strd]
Phase [tmco]
months [tmco]
treatment [ftcn]
Pulsatility index [clna]
Uterine Arteries [bpoc]
Lower [spco]
baseline [bodm]
P NOS [aapp, imft]
Evaluated [ftcn]
Combined [qlco]
Phase [tmco]
Conclusions [idcn]
Transdermal Administration [ftcn]
Sequential [idcn]
Estradiol [horm, phsu, strd]
Norethisterone [horm, phsu, strd]
Uterine Artery [bpoc]
Resistance [menp]
Induce [ftcn]
Self [idcn]
limiting [ftcn]
Uterus [bpoc]
Endometrium [bpoc]
Menopause [phsf]
[c] [qnco]
North American [fndg]
Menopause [phsf]
society [orgt]
